-
Anti-ROR1 Antibody: Translational Workflow
2026-09-15
Build a rigorous ROR1 workflow spanning immobilized-protein binding, flow cytometry, and functional signaling studies with Zilovertamab. The article also shows how to use ROR1 measurements as a carefully bounded exploratory layer in deoxynivalenol liver-injury research without confusing an oncology reagent with evidence of a hepatic mechanism.
-
Cisplatin (CDDP) Cancer Research Workflows
2026-09-15
Build reproducible Cisplatin workflows for DNA damage, viability, apoptosis, and chemotherapy resistance studies. The guide translates a recent nasopharyngeal carcinoma study into practical assay choices while addressing formulation, timing, controls, and xenograft-readout challenges.
-
Cy3 Goat Anti-Mouse IgG (H+L) Antibody Guide
2026-09-14
Cy3 Goat Anti-Mouse IgG (H+L) Antibody is a Cy3-labeled secondary reagent for detecting mouse primary antibodies in immunofluorescence, flow cytometry, and western blot workflows. It should be qualified experimentally for each assay and is not presented as a diagnostic reagent or as a substitute for directly matched paper validation.
-
Pharmacological Chaperones Restore GABAA Proteostasis
2026-09-14
The reference study shows that several epilepsy-associated GABAA receptor α1 variants are loss-of-function defects linked primarily to impaired folding, assembly, trafficking, and degradation. It further identifies Hispidulin and TP003 as pharmacological chaperones that improve receptor surface expression and function in cellular models without inducing a detectable unfolded protein response.
-
GSK2606414 Workflow for ER Stress Research
2026-09-13
Build a time-resolved PERK assay that connects eIF2α signaling, translational control, and cell fate to practical ER stress research. This workflow also adapts the reference study’s progressive infection design to test how PERK activity may intersect with Nrf2-dependent redox defense without overstating the available evidence.
-
Perphenazine: From Receptor Pharmacology to Assay Design
2026-09-12
Perphenazine is a dopamine D2 receptor antagonist with a distinctive phenothiazine receptor profile. This article translates its neuropharmacology, mitochondria-mediated cell death induction, and emerging host-directed antibacterial evidence into practical assay-design decisions.
-
Neticonazole Hydrochloride Research Workflows
2026-09-12
Neticonazole Hydrochloride connects practical cutaneous candidiasis assays with an emerging colorectal cancer research use case. This guide covers fresh-solution preparation, microscopy, fungal susceptibility testing, exosome analysis, Bcl-2/Bax readouts, and troubleshooting without treating preclinical oncology findings as clinical evidence.
-
Epoxomicin: Selective Proteasome Inhibition
2026-09-11
Epoxomicin is a selective, irreversible proteasome inhibitor that covalently targets the 20S proteasome through its α',β'-epoxyketone group. Its 4 nM vendor-reported IC50 for chymotrypsin-like activity makes it useful for ubiquitin-proteasome pathway research, protein degradation assays, and proteostasis models.
-
Indole-3-pyruvic Acid: From Auxin to Translation
2026-09-11
Indole-3-pyruvic acid (IPA) is more than an auxin biosynthesis intermediate: it is a mechanistically informative tryptophan metabolite that connects plant hormone research, fungal genetics, and immune modulation via AhR. This thought-leadership guide shows how translational researchers can use IPA to design stronger pathway, pharmacology, and preclinical studies.
-
5-(N,N-dimethyl)-Amiloride in pH Research
2026-09-10
5-(N,N-dimethyl)-Amiloride hydrochloride is a mechanistic tool for separating Na+/H+ exchanger activity from endothelial inflammation, barrier failure, and cardiac ion dysregulation. This guide translates its isoform profile into practical workflows for intracellular pH regulation, sepsis-related endothelial injury, and ischemia-reperfusion studies.
-
Frizzled5 Connects Cholesterol to Wnt Signaling
2026-09-10
The reference study identifies Frizzled5 as a cholesterol-sensitive Wnt receptor that connects lipid metabolism with β-catenin signaling in pancreatic ductal adenocarcinoma. Its experiments suggest that cholesterol binding in the receptor linker promotes palmitoylation, receptor maturation, and plasma-membrane trafficking, while 25-hydroxylsterol can disrupt this process.
-
MLN2238 as a Proteotoxic Stress Sensor
2026-09-09
MLN2238 is a potent proteasome β5 subunit inhibitor that can be used not only for oncology studies, but also to map adaptive proteotoxic-stress signaling. This article develops an assay-centered framework connecting proteasome inhibition with ROS, JNK, and CRTC-CREB responses.
-
Annexin-V Mapping of Cardiomyocyte Death After I/R
2026-09-09
This Circulation study introduced labeled recombinant human annexin-V as an in situ marker of phosphatidylserine exposure during myocardial ischemia and reperfusion in mice. By resolving cell-death timing and responding to pharmacological intervention, the approach provided a more actionable readout than DNA-fragmentation assays alone.
-
Mithramycin A: Workflow for Sp1-Linked Research
2026-09-08
Mithramycin A is an anticancer antibiotic that converts G-C-rich DNA binding into a practical perturbation strategy for transcription, c-myc, and differentiation studies. This guide connects cancer assays with the miR-24-3p/Sp1/PI3K findings from a cardiac injury model while clearly separating established evidence from assay-development recommendations.
-
IGF2BP1–TUBB4B Axis in Liver Fibrosis
2026-09-08
The reference study identifies an m6A-dependent IGF2BP1–TUBB4B–FAK pathway that promotes hepatic stellate cell activation, proliferation, and migration. Its combination of transcriptomic re-analysis, RNA-binding and methylation profiling, genetic perturbation, and pharmacological testing provides a useful framework for interpreting post-transcriptional mechanisms in liver fibrosis.